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Conclusions: In this first-in-human feasibility study, the theoretical concerns of higher-
frequency IVUS were not documented in clinical settings, demonstrating a comparable
ability of 60MHz imaging in measurements of diseased coronary arteries as compared
with conventional 40MHz imaging.
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Background: The vascular tissue reaction to acute incomplete stent apposition (ISA) is
scarcely known. The aim of this study is characterizing the vascular response to acute ISA
in vivo and looking for predictors of incomplete healing.
Methods: Optical coherence tomography studies from 3 randomized trials including
different types of stents were sequentially analysed after implantation and at 6-13 months.
Segments with acute ISA were matched with the follow-up study using fiduciary
landmarks. The pattern of healing was categorized according to morphologic criteria.
Volumetric and per strut analysis (apposition and coverage) were performed. Predictors
for ISA correction and for completeness of coverage were sought.
Results: 66 stents (43 patients) were sequentially analyzed. 78 ISA segments were
identified. ISA volume decreased and 71.5% of the ISA segments were spontaneously
corrected at follow-up. Coverage of acute ISA segments is delayed with respect to
well-apposed segments (RR 2.37; 95% CI 2.01 – 2.78). ISA coverage depended on the
type of stent, but acute ISA volume was the only independent predictor for persistent ISA
(OR 3.19, 95% CI 1.43 – 7.12) and for massively delayed coverage (OR 1.37, 95% CI
1.09 – 1.74). Acute ISA size (estimated as ISA volume or maximal ISA distance per strut)
was an independent predictor of ISA persistence and of delayed healing at follow-up.
Maximal ISA distances 270 m post stent implantation appeared grossly covered and
spontaneously re-apposed in 100% of cases at follow-up; whilst maximal ISA distances
850 m) resulted in persisting ISA and grossly delayed coverage in 100% of cases.
Conclusions: The neointimal healing tends to reduce ISA, often integrating it completely
into the vessel wall and resulting in characteristic morphologic patterns. Coverage of ISA
segments is delayed with respect to well-apposed segments. The larger the size of acute
ISA, the larger the likelihood of persisting malapposed at follow-up and of delayed
healing.
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Background: Intravascular NIRS is well-validated for coronary lipid core plaque (LCP)
detection. Initial work has shown ability to differentiate LCP cap thickness by relative
cholesterol/collagen contribution to overall signal. This study assessed NIRS vs histology
LCP cap thickness in coronary autopsy specimens using improved multivariate methods,
reproducibility, and clinical applicability.
Methods: NIRS was performed through blood in 212 coronary segments from 84
autopsy hearts. Histologic sections were analyzed every 2mm, and fibrous cap thickness
in each LCP section was measured. Accuracy of classifying fibrous caps as thin
(65m), intermediate, or thick (400m) was tested for a combined-model approach
using cross-validation.
Results: Thin regions were present in 70/901 (7.8%) sections and thick regions were
present in 120/901 (13.3%) sections. The algorithm classified thin and thick fibrous cap
regions with an AUC of 0.78 (95% CI:0.72-0.85). Very good reproducibility for separate
catheter acquisitions was demonstrated: correlation coefficients of 0.96 for thin regions
and 0.92 for thick regions. A retrospective analysis of fibrous cap thickness conducted in
clinical NIRS scans containing LCPs, shows applicability of the technique to in vivo
images.
Conclusions: This novel catheter-based NIRS system already in clinical use to identify
LCPs in patients, accurately and reproducibly classified fibrous caps overlying LCP
through blood in coronary autopsy specimens. Assessment of fibrous cap thickness may
be of value in management of patients with coronary artery disease and development of
anti-athero drugs.
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Background: After the first-in-man REMEDEE Study report, the dual therapy COMBO
Stent (OrbusNeich Medical, FL, USA) was further evaluated for its in-vivo pro-healing
benefit and neointimal suppression as a DES in this Study.
Methods: In this prospective, single center study, 61 patients treated by COMBO Stent
(9 months DAPT) were randomly assigned to 4 monthly groups (2nd to 5th month,
1:2:2:1 ratio). OCT was performed sequentially 3 times at baseline PCI, early follow-up
in 4 monthly groups (for early stent coverage using 6 stringent Categories; every frame &
strut analyzed), and then 9 months (for OCT neointima analysis; every 5 frames). Clinical
event adjudication, core lab. QCA & OCT analyses were undertaken by Cardiovascular
Research Foundation, NY.
Results: 61 patients (32% DM) received 88 COMBO stents. From 2nd to 5th monthly
group, covered struts % increased significantly from 77.2%, 82.2%, 91.5% to 98.1%
(100% coverage at 150 days; refer to Figure). At 9 months, mean OCT neointimal
thickness was 0.135mm and area 1.259 mm2, with a corresponding QCA late loss of
0.31mm. At 9-month FU, 1 patient had non-ischemic angiographic stenosis treated by
simple ballooning; otherwise no other MACE (restenosis nor stent thrombosis) was
recorded to date, totaling a MACE rate of only 1.64% (1/61) throughout a mean FU period
of 508 days. Final core lab. results are pending.
Conclusions: The COMBO stent is the first DES with a healing profile established (rapid
strut coverage). The promising outcomes after almost 18 months FU appeared to support
the benefits of the dual therapy approach.
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